Post-therapy imaging and dosimetry significantly enhance patient management, empowering clinicians to make more informed, ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

In a UK study, whole-body MRI reveals underrecognised musculoskeletal inflammation in patients on immune checkpoint ...

Far from science fiction, AI is already embedded in hundreds of FDA-cleared tools and is projected to multiply the value of ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

A brain abscess is a rare but life-threatening infection. Learn how advances in imaging, surgery, and diagnostics are ...

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and ...

Arlington Heights, Illinois Thursday, June 26, 2025, 13:00 Hrs [IST] ...

Perspective Therapeutics, Inc. ("Perspective” or the "Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, announced two ...